健保藥品HTA評估報告
| 序號 | 標題 | 檔案類型 |
|---|---|---|
| 21 | 羅視萌注射劑 (Vabysmo solution for intravitreal injection) |
|
| 22 | 杜避炎注射劑 (Dupixent) 氣喘 |
|
| 23 | Torsix® injection 10mg/mL 2mL 及5mL |
|
| 24 | 百悅澤膠囊 (Brukinsa) |
|
| 25 | Uritos Tablets 0.1 mg |
|
| 26 | 修訂含SGLT-2 抑制劑與DPP-4 抑制劑複方製劑(如Steglujan、Glyxambi 及Qtern)藥品給付規定 |
|
| 27 | 吉舒達注射劑 (Keytruda Injection) NSCLC |
|
| 28 | 吉舒達注射劑 (Keytruda Injection) HNSCC |
|
| 29 | Tecentriq injection, for intravenous use, 1200mg/20ml |
|
| 30 | 維泰凱 (Vitrakvi) |
|
| 31 | 喜繽果100毫克及200毫克膜衣錠 (Cibinqo 100mg、200mg film-coated tablets) |
|
| 32 | Galafold |
|
| 33 | PhosAdd Tab. |
|
| 34 | 克瘤康膠囊 (Calquence Capsules) |
|
| 35 | 祈萊亞靜脈輸注用懸浮液 (Kymriah® suspension for intravenous infusion)_ALL |
|
| 36 | Tremsolin Tablets 50mg、250mg |
|
| 37 | 修訂血栓溶解劑含rt-PA 成分藥品(如Actilyse)之給付規定 |
|
| 38 | Dufanas Nasal Spray |
|
| 39 | 芮寶喜凍晶注射劑 (Reblozyl) |
|
| 40 | Fulphila |
|